Protara Therapeutics, Inc. (TARA) Total Assets by Year
Protara Therapeutics, Inc. closed fiscal year 2025 with $209.5M in total assets, $13.1M in total liabilities and $196.4M in shareholder equity. This represents an increase of 15.4% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Protara Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TARA Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $209.5M+15.4% | $181.5M+129.8% | $79.0M-30.3% | $113.3M-34.4% | $172.6M-15.0% | $203.2M+16511.4% | $1.2M-94.8% | $23.5M-46.5% | $44.0M+1.1% | $43.5M-35.6% | $67.5M-20.4% | $84.8M+1398.5% | $5.7M | N/A |
| Total Liabilities | $13.1M-8.8% | $14.3M+34.7% | $10.6M-5.1% | $11.2M+4.9% | $10.7M+172.9% | $3.9M+16.8% | $3.4M-82.1% | $18.7M+102.8% | $9.2M+81.9% | $5.1M+22.9% | $4.1M+76.8% | $2.3M-97.8% | $106.2M | N/A |
| Total Equity | $196.4M+17.5% | $167.1M+144.6% | $68.3M-33.1% | $102.1M-37.0% | $161.9M-18.7% | $199.2M+9462.9% | -$2.1M-144.5% | $4.8M-86.2% | $34.7M-9.6% | $38.4M-39.4% | $63.4M-23.1% | $82.5M+182.0% | -$100.5M-16.0% | -$86.7M |
TARA Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $176.1M+12.2% | $191.9M+13.9% | $209.5M+15.4% | $144.6M+53.7% | $156.9M+54.4% | $168.6M+147.4% | $181.5M+129.8% | $94.1M+6.4% | $101.6M+6.8% | $68.1M-36.0% | $79.0M-30.3% | $88.5M-40.5% |
| Total Liabilities | $14.8M+18.2% | $10.7M+6.4% | $13.1M-8.8% | $12.3M+0.4% | $12.5M+30.4% | $10.1M+3.6% | $14.3M+34.7% | $12.3M+6.8% | $9.6M-3.2% | $9.7M-16.4% | $10.6M-5.1% | $11.5M+22.3% |
| Total Equity | $161.3M+11.7% | $181.2M+14.3% | $196.4M+17.5% | $132.3M+61.7% | $144.4M+56.9% | $158.5M+171.3% | $167.1M+144.6% | $81.8M+6.3% | $92.0M+8.0% | $58.4M-38.4% | $68.3M-33.1% | $77.0M-44.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Protara Therapeutics, Inc. financials
Frequently Asked Questions
What was Protara Therapeutics, Inc.'s total assets in fiscal year 2025?
Protara Therapeutics, Inc. closed fiscal year 2025 with $209.5M in total assets, $13.1M in total liabilities and $196.4M in shareholder equity.
How fast is Protara Therapeutics, Inc.'s total assets growing?
Protara Therapeutics, Inc. (TARA) total assets rose by 15.4% year over year, from $181.5M to $209.5M in fiscal year 2025.
What was Protara Therapeutics, Inc.'s total assets in the most recent quarter?
Protara Therapeutics, Inc. (TARA) reported $176.1M in total assets in Q2 2026. This represents an increase of 12.2% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Protara Therapeutics, Inc. (TARA) reported on that line in every period on record.